Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections.
D000743:Anemia, Hemolytic / Q000209:etiology; D002509:Cephaloridine / Q000627:therapeutic use; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use*; D013293:Enterococcus faecalis / Q000187:drug effects*; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications; D006801:Humans; D008297:Male; D011014:Pneumonia / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects*; D013291:Streptococcus / Q000187:drug effects*; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D002511:Cephalosporins; D002509:Cephaloridine